The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation
Keyword(s):
2018 ◽
Vol 3
(4)
◽
pp. 115-119
Keyword(s):
1982 ◽
Vol 73
(4)
◽
pp. 582-595
◽
Keyword(s):
Keyword(s):